← Leaderboards
Matig R Mavissakalian
Case Western Reserve University
$304,681
Attributed
$304,681
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$304,681 · 3
By mechanism
R01$285,482 · 1
M01$19,199 · 2
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Katherine L. Wisner$16,545,298
- Robert L Findling$16,428,028
- Shibani Mukerji$5,492,935
- Peter Scott Heeger$92,873,534
- Joseph R Calabrese$3,248,037
Others in their field
Top investigators on “Agoraphobia”
- Martin B Keller · Brown University$5,781,564
- Jerrold F Rosenbaum · Massachusetts General Hospital$5,653,606
- David H. Barlow · Boston University$2,628,618
- William Anthony Truitt · Indiana University Indianapolis$2,598,138
- Ronald C Kessler · Harvard Medical School$2,376,193
- Barbara L Milrod · Weill Medical College Of Cornell Univ$2,342,295
Research focus
AgoraphobiaClinical ResearchHuman SubjectHuman Therapy EvaluationMental Disorder ChemotherapyPanic DisorderDrug Screening /EvaluationLongitudinal Human StudyImipramineDrug WithdrawalRelapse /RecurrenceTricyclic AntidepressantDrug Administration Rate /DurationSerotonin InhibitorPlacebosAntidepressantsBehavioral /Social Science Research TagHealth Care Cost /FinancingPsychopharmacologyQuality Of LifeClinical TrialsDisease /Disorder Proneness /RiskTherapy ComplianceHuman Middle Age (35-64)
Grant awards (7)
ANTIDEPRESSANTS IN ANXIETY DISORDERS--DISCONTINUATION/MAINTENANCE W/ IMIPRAMINE$0
M01 · FY2002 · RR
Safety/efficacy of Lu26-054/citalopram/placebo in panic$0
M01 · FY2002 · RR
Safety/efficacy of Lu26-054/citalopram/placebo in panic$0
M01 · FY2001 · RR
ANTIDEPRESSANTS IN ANXIETY DISORDERS--DISCONTINUATION/MAINTENANCE W/ IMIPRAMINE$0
M01 · FY2001 · RR
ANTIDEPRESSANTS IN THE TREATMENT OF ANXIETY DISORDERS$285,482
R01 · FY2000 · MH
ANTIDEPRESSANTS IN ANXIETY DISORDERS--DISCONTINUATION/MAINTENANCE W/ IMIPRAMINE$19,199
M01 · FY2000 · RR
Safety/efficacy of Lu26-054/citalopram/placebo in panic$0
M01 · FY2000 · RR